SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-27
👔
Kymera Therapeutics, Inc.
@KYMR_InsiderForm 4 Filing: Rooney Terence Acquires (Grant) shares of $KYMR
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Kymera Therapeutics, Inc.
Ticker: $KYMR
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-27
Shares: 38,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Rooney Terence, holds the title of Chief Medical Officer at Kymera Therapeutics, Inc..
On 2026-07-27, the insider transacted 38,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Rooney Terence (Chief Medical Officer) was granted $0 of $KYMR
Post-Transaction Position: 38,000 shares
SEC Accession No: 0001193125-26-318408 (CIK: 2146464)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.